Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

News Industry News

Neuravi Announces European Launch of Innovative Minimally Invasive Stroke Therapy

October 01, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Industry News

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

September 14, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

News Industry News

Bradycardia Patients Test Drive Pacemakers

June 24, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval of the World’s Only MultiPoint Pacing Pacemaker

December 10, 2014

News Industry News

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

July 30, 2014

News Industry News

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

June 06, 2014

News Industry News

SORIN GROUP ANNOUNCES FREEDOM SOLO FDA STUDY RESULTS AT THE AATS 2014 SCIENTIFIC SESSIONS

May 12, 2014

News Industry News

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

May 07, 2014

News Industry News

New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat

May 07, 2014

News Industry News

Trial Finds Benefits to Using Radial Versus Femoral Access for Primary Angioplasty in Heart Attack Patients

October 26, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Industry News

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

February 29, 2012

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

Advertisement

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

Neuravi Announces European Launch of Innovative Minimally Invasive Stroke Therapy

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

Bradycardia Patients Test Drive Pacemakers

St. Jude Medical Announces CE Mark Approval of the World’s Only MultiPoint Pacing Pacemaker

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

SORIN GROUP ANNOUNCES FREEDOM SOLO FDA STUDY RESULTS AT THE AATS 2014 SCIENTIFIC SESSIONS

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

New registry data highlight substantial global differences in stroke prevention for patients with an irregular heart beat

Trial Finds Benefits to Using Radial Versus Femoral Access for Primary Angioplasty in Heart Attack Patients

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content